| 【公司研究】比亞迪控股 - A (002594 CH) – 受益於磷酸鐵鋰表現出色 |
| 【Company Research】Antengene Corporation Limited (6996 HK) – Leading Asia-Pacific biopharmaceutical company developing first-in-class SINE compounds |
| 【公司研究】興達國際 (1899 HK) – 銷量和毛利共同推動盈利覆蘇 |
| 【行業研究】中國房地產 – 市場對貸款上限反應過度後；良好買入時機 |
| 【公司研究】天倫燃氣 (1600 HK) – 新項目並購將提升2021年收益 |
| 【Fixed Income Research】Yestar – can it avert a default? (YESTHEA) |
| 【Company Research】Simcere Pharmaceutical Group (2096 HK) – Transitioning from generic to innovative |
| 【Company Research】CIMC Vehicles (Group) (1839 HK) – More catalysts in 2021E |
| 【Company Research】China Technology Sector – Global smartphone recovery to continue in 2021; Prefer share gainers and Xiaomi/Apple plays |
| 【Company Research】China Technology Sector – Time to revisit China 5G supply chain; Positive catalysts on the horizon |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
